The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery

Ann Surg. 2017 Dec;266(6):e61-e62. doi: 10.1097/SLA.0000000000001502.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Inflammatory Bowel Diseases*
  • Infliximab
  • Postoperative Period
  • Tumor Necrosis Factor-alpha*

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab